Clinical Trials
20 trialsNCT06172127 2026-04-29
DEMETHER
MedSIR
Phase 2 Active not recruiting
NCT06009627 2026-02-10
Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients
Tianjin Medical University Cancer Institute and Hospital
Phase 2/3 Completed
NCT07209436 2026-01-22
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction
Massachusetts General Hospital
Phase NA Recruiting
NCT06220214 2026-01-15
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Stony Brook University
Phase EARLY_PHASE1 Recruiting
NCT04778839 2025-08-06
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
First Affiliated Hospital of Zhejiang University
Phase 1 Recruiting
NCT07106112 2025-08-06
COMET
Saint Petersburg State University, Russia
Phase NA Recruiting
NCT06199895 2025-06-03
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer
Tongji Hospital
Phase 2 Recruiting
NCT05332561 2025-03-20
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
German Cancer Research Center
Phase 2 Recruiting
NCT06633601 2024-10-09
MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer
Sunnybrook Health Sciences Centre
Phase 1 Recruiting
NCT05711030 2024-02-20
TPVB
Ciusss de L'Est de l'Île de Montréal
Phase NA Unknown
NCT04431674 2023-12-13
USmBRT-B
Sunnybrook Health Sciences Centre
Phase 1 Completed
NCT03121989 2023-03-30
LABC
Sunnybrook Health Sciences Centre
Phase 1 Withdrawn
NCT02652923 2023-01-23
Contrast Ultrasound Detection of Sentinel Lymph Nodes
Thomas Jefferson University
Phase 1/2 Completed
NCT05621434 2022-11-18
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Fujian Medical University
Phase 2 Unknown
NCT02897050 2022-04-20
Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Suspended
NCT03139851 2021-09-10
CHEMOIMMUNE
Centre Leon Berard
Phase 2 Completed
NCT02953184 2017-12-29
Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy
Jilin University
Phase 2 Unknown
NCT01765309 2013-01-14
A Randomized Controlled Trial To Evaluate The Use Of Botox In Breast Reconstruction With Tissue Expanders
University of Colorado, Denver
Phase NA Completed
NCT01428414 2012-08-23
Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer
Fudan University
Phase 2 Unknown
NCT00955890 2012-02-28
cardioprotec
Fudan University
Phase 2 Terminated